Niranjan Kameswaran | Senior Vice President, Strategy |
Mary Reumuth | Chief Financial Officer |
Mark Iwicki | Chairman, President and Chief Executive Officer |
Kim Brazzell | Chief Medical Officer |
Todd Bazemore | Chief Operating Officer |
Chris Neyor | JP Morgan |
Liana Moussatos | Wedbush Securities |
Biren Amin | Jefferies LLC |
Yi Chen | H.C. Wainwright & Co. |
Tazeen Ahmad | Bank of America Merrill Lynch |
Good morning, and welcome to Kala Pharmaceuticals’ First Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, a Q&A session will be held.
As a reminder, this call is being recorded.
I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals.